The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.
Follow this section to personalize your feed and get instant alerts. Update your preferences in Account Settings Follow this tag to personalize your feed and get instant alerts. Follow this author to personalize your feed and get instant alerts.
Extract — continue reading at the source.
Similar stories
2 outlets
See how this story developed, hour by hour
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
nytimes.com
22.10.2026
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
arstechnica.com
23.10.2026
Related stories
'Resident Evil Outbreak' Is Finally Playable Online With Friends for Free
Your Guide to the ‘Grey’s Anatomy’ Season 23 Cast and Characters
Here’s When Every Episode of ‘The Terminal List’ Season 2 Drops
I thought I was dying but it was health anxiety - here's how to recognise the signs
Private care home investors a risk to public sector, regulator says
Give more people weight loss jabs on the NHS, say MPs